Biospecimen Collection - blood and tissue sample collection for Carcinoma
This study is evaluating whether a personalized ctDNA test can be used to guide treatment for patients with gastrointestinal cancer with peritoneal carcinomatosis.
See full descriptionAbout the trial for Carcinoma
Treatment Groups
This trial involves 2 different treatments. Biospecimen Collection - Blood And Tissue Sample Collection is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Eligibility
This trial is for patients born any sex aged 18 and older. There are 10 eligibility criteria to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether Biospecimen Collection - blood and tissue sample collection will improve 2 primary outcomes and 5 secondary outcomes in patients with Carcinoma. Measurement will happen over the course of Baseline, pre-surgery, 3-4 weeks post-surgery and every 3 months up to 2 years after cytoreductive surgery (CRS).
Who is running the study
Principal InvestigatorPatient Q & A Section
Have there been other clinical trials involving biospecimen collection - blood and tissue sample collection?
The collection of biospecimens has an important role for the advancement of medical science and its application in personalized medicine. We present two clinical trials where a biospecimen collection was used to advance the field of OBCS. These studies provide evidence that biospecimen collections could be utilized to further our understanding of the pathophysiology of certain diseases.
Does carcinoma run in families?
Carcinoma has been found to be associated with some hereditary conditions, but this association is often weak. A family history of carcinoma does not predict the occurrence of carcinoma, and when present does not seem to modify the age at onset. [Power(http://www.withpower.com/clinical-trials/carcinoma)]: We want to know if familial cancers have different features compared to sporadic cancers. We want to find out why cancer occurs so frequently in relatives of patients with cancer.
What is the primary cause of carcinoma?
Diseases caused by smoking have been recognized since 1872.. Chronic infections such as hepatitis B virus, hepatitis C virus, and human immunodeficiency virus, as well as environmental factors such as diet, physical activity, and alcohol use, may increase the risk for developing certain types of cancers. Tobacco smoke increases the risk of lung cancer, squamous cell carcinoma of the head and neck, prostate cancer, bladder cancer, colorectal cancer, pancreatic cancer, and esophageal cancer.
What is carcinoma?
The International Agency for Research on Cancer (IARC) states that carcinoma is cancer of epithelial cells and are classified into 3 types based on their origin:\n\n1. Squamous cell carcinoma - originating from epithelial cells of squamous tissue.\n2. Adenocarcinoma - originating from glandular epithelium in organ ducts.\n3. Carcinoid tumours - originating from neuroendocrine cells in glands or from other tissues.
What is the survival rate for carcinoma?
The survival rate for carcinoma depends on several factors, such as stage at diagnosis, histological type, and presence of metastases. Survival rates vary depending on the primary site of origin and the subtype. The 5-year survival rate for carcinoma is approximately 80%. Teaching of medical students about carcinoma is important for them to understand how the survival rate varies and how these factors influence survival.
How does biospecimen collection - blood and tissue sample collection work?
Biospecimen collection may be affected by multiple factors including patient characteristics, type of biopsy specimen collected, and time interval between initiation of collection and receipt of the specimen at the laboratory.
What are the latest developments in biospecimen collection - blood and tissue sample collection for therapeutic use?
The majority of studies on biospecimen collections have been focused mainly on blood and related specimens and have primarily service medical applications. The number of studies investigating samples collected from other sites is increasing, particularly during the last decade, and is expected to continue. Most studies focus on whole-blood samples, serum or plasma, although some research has been conducted on cell-free nucleic acids, which are a key component of many biological fluids. The need for further development of the field remains evident.
What are the chances of developing carcinoma?
The chances of developing carcinoma upon stopping DHT are low, especially among men who were younger than 30 years at baseline. Carcinoma is much more likely to occur in women than in men after starting DHT.
How many people get carcinoma a year in the United States?
Carcinoma is the second-most common cause of death among women aged 65 and older in the US. It accounts for approximately 8% (1,813,000) of all deaths in this age group.
Has biospecimen collection - blood and tissue sample collection proven to be more effective than a placebo?
Biospecimen collections are effective in identifying participants with PBC and in aiding in the characterization of histologic subtypes. Participants who had undergone biopsy (PBC-only) were more likely to be diagnosed at an earlier stage than those receiving just blood sampling.
What causes carcinoma?
The most common hypotheses explaining cancer are the genetic defect hypothesis and the environmental hypothesis. But we cannot be sure about the real cause of over 90% of all cancers because we have so little knowledge about this topic. In fact, we still don't know what causes cancer. So we need to focus our research on this problem. We will continue to ask questions like 'what causes cancer' and 'what helps people stay healthy'. The answer to these questions may eventually lead us to discover something useful for preventing cancer. Clinicians should remember to examine their patients with caution, because although the majority of cancers occur when a person is middle aged or older, many cancers (e.g., lung cancer) occur at young ages.